EnBio Holdings Reports Fiscal Year 2025 Financial Results with Revenue Growth Amid Profit Decline

The latest announcement is out from EnBio Holdings, Inc. ( (JP:6092) ).

EnBio Holdings, Inc. reported its consolidated financial results for the fiscal year ended March 31, 2025, showing an increase in net sales by 11.4% to ¥10,668 million. However, the company experienced a decline in ordinary profit and profit attributable to owners of the parent by 34.2% and 36.1%, respectively. The financial results reflect challenges in maintaining profitability despite revenue growth. The inclusion of two new companies, DEFNE ENERGY INVESTMENT INDUSTRY TRADE LIMITED and EnBio C West, G.K., in its consolidation scope indicates strategic expansion efforts. The forecast for the next fiscal year predicts further growth in net sales and profits, suggesting a positive outlook for the company’s future performance.

More about EnBio Holdings, Inc.

EnBio Holdings, Inc. is a company listed on the Tokyo Stock Exchange, primarily engaged in the energy investment industry. The company focuses on expanding its market presence through strategic investments and acquisitions.

Average Trading Volume: 9,587

Technical Sentiment Signal: Sell

Current Market Cap: Yen4.69B

For a thorough assessment of 6092 stock, go to TipRanks’ Stock Analysis page.